The way we use medication for anxiety is changing rapidly, creating a new level of hope for the millions of people in America who still have trouble with anxiety symptoms that can’t be treated with traditional medications or talking therapies. Up until very recently, there were not very many options available to treat someone who had been diagnosed with generalised anxiety, panic disorder, or health related worry. The only medical treatments available were SSRIs, benzodiazepines and/or CBT. There are many new studies that are starting to change how we treat anxiety and for how long anxiety treatments are effective.
The most visible advancement in the treatment of anxiety has been the advent of a new group of medications based on psychedelics. In recent research studies, an involved compound derived from LSD known as MM120 was given to patients suffering from generalized anxiety disorder in a controlled environment. The results showed that a single dose of this medication, administered only once, could alleviate anxiety symptoms for several weeks or longer. The success of these Phase 2 clinical trials has led researchers to justify advancing to Phase 3 clinical trials, thus raising the possibility of seeing the first new class of anxiety medications in almost 20 years in the U.S.
In addition to pharmacological advancements, researchers are looking for ways to enhance the effectiveness of anxiety treatment through the use of technology. Virtual reality exposure therapy allows patients to face their fears or triggers over time, while digital CBT platforms are designed to provide patients with structured programming on their smartphones so that they can develop skills through practice between sessions.
Neuroscience-informed devices, such as Neuromodulation devices and biofeedback wearables, are utilized to improve it. Anxiety suffers often do not understand what is causing their level of physiological response to stress that leads them to feel anxious and avoid confronting anxiety-inducing scenarios. It is important for clinicians to emphasize that these new and innovative methods are designed to be used as an adjunct to and not a substitute for the human connection that is at the core of successful anxiety treatment. There is also concern about equity and access to these innovative options in anxiety treatment. Experts have expressed concerns that without an intentional effort from policy makers to implement well-thought-out policies regarding equity, there could be a situation where the cutting-edge treatments available could become available only to certain patients due to factors such as coverage, cost, or geographic location.
Despite this challenge, many researchers and clinicians are cautiously optimistic. After many years in which numerous patients have had limited access to an already narrow range of treatment options, there are now an abundance of innovative and exciting options being developed. If regulators, payers, and providers can collaborate in a meaningful way during the next three years, 2026 could be the beginning of a new era of more personalized, effective, and hopeful treatment for those who suffer from anxiety disorders.
Source: Compass Associates – Future Anxiety Treatment Research; UCSF – Novel Therapy for Anxiety
Leave a Comment